Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-28228

Single-particle
3.6 Å
EMD-28228 Deposition: 24/09/2022
Map released: 19/07/2023
Last modified: 06/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-28228

SARS-CoV-2 spike glycoprotein in complex with the ICO-hu23 neutralizing antibody Fab fragment

EMD-28228

Single-particle
3.6 Å
EMD-28228 Deposition: 24/09/2022
Map released: 19/07/2023
Last modified: 06/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 spike glycoprotein in complex with the ICO-hu23 antibody Fab fragment
Fitted models: 8elj

Deposition Authors: Yee AW, Morizumi T, Kim K, Kuo A, Ernst OP
Broadly neutralizing humanized SARS-CoV-2 antibody binds to a conserved epitope on Spike and provides antiviral protection through inhalation-based delivery in non-human primates.
PUBMED: 37531329
DOI: doi:10.1371/journal.ppat.1011532
ISSN: 1553-7374
Grant Support: